Terms: = Sarcomas AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Clinical Outcome
2 results:
1. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia.
Xu LH; Wang Y; Chen ZY; Fang JP
J Cancer Res Clin Oncol; 2020 Apr; 146(4):1011-1020. PubMed ID: 31919567
[TBL] [Abstract] [Full Text] [Related]
2. mll-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia.
Manara E; Baron E; Tregnago C; Aveic S; Bisio V; Bresolin S; Masetti R; Locatelli F; Basso G; Pigazzi M
Blood; 2014 Jul; 124(2):263-72. PubMed ID: 24695851
[TBL] [Abstract] [Full Text] [Related]
